Results 111 to 120 of about 1,763,079 (280)

Nonthermal plasma approaches for combating implant‐associated infections: A compendious review

VIEW, EarlyView.
Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe, Satish Rojekar, Amol Gholap, K. Navaneetha Pandiyaraj, Mukesh Patekar, Claudia Riccardi, R. R. Deshmukh, Tomáš Kovářík, Kalim Deshmukh   +8 more
wiley   +1 more source

National Practice Patterns of VA ECMO and Left Ventricular Mechanical Unloading for Cardiogenic Shock

Artificial Organs, EarlyView.
Consensus surrounding the management of VA ECMO and left ventricular mechanical unloading for cardiogenic shock (CS) is limited. We thus conducted a national survey of practice patterns in the treatment of CS to characterize such variability, finding large heterogeneity in CS diagnosis, VA ECMO initiation, and LVMU strategies.
Dustin M. Anderson‐Bell, Morgan M. Millar, Rachel R. Codden, Stavros Drakos, Craig Selzman, Chloe R. Skidmore, Margaret Carlson, Frederick Welt, Tom Hanff, Hiroshi Kagawa, Jason Glotzbach, Andrea Steely, Vikas Sharma, Matt Goodwin, Daniel Haase, Jason Carr, Joseph E. Tonna   +16 more
wiley   +1 more source

Post‐Market Analysis of the Xenios Console With the Xlung Tubing Kit 230 for Extracorporeal Membrane Oxygenation After Cardiac Surgery

Artificial Organs, EarlyView.
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci, Anne‐Kristin Schaefer, Thomas Schlöglhofer, Emilio Osorio‐Jaramillo, Amila Kahrovic, Alvaro Perazzo, Marcus Granegger, Daniel Zimpfer, Dominik Wiedemann, Julia Riebandt   +9 more
wiley   +1 more source

In vivo performance of a tri-leaflet mechanical heart valve prosthesis in an ovine model. [PDF]

Interdiscip Cardiovasc Thorac Surg, 2023
Langenaeken T, De Meester P, Verbrugghe P, Rega F, Lamberigts M, Van Hecke M, Van Hoof L, Meuris B.   +7 more
europepmc   +1 more source

An Optimized Multi‐Stage Drainage Cannula Design for Venoarterial Extracorporeal Membrane Oxygenation

Artificial Organs, EarlyView.
This study utilized an extensive optimization involving n = 540 design of experiments to produce a superior drainage cannula design. Compared to the clinically used Maquet model, our optimized design demonstrated reduced blood stagnation volumes, increased cannula tip velocities, and higher upper body drainage, potentially minimizing risk of thrombosis
Avishka Wickramarachchi, Mehrdad Khamooshi, Aidan Burrell, Shaun D. Gregory   +3 more
wiley   +1 more source

Evaluation of TTK Chitra heart valve prosthesis in pediatric patients. [PDF]

Indian J Thorac Cardiovasc Surg, 2023
Varma PK, Kumar RK, Bhuvaneshwar GS, Krishna N.   +3 more
europepmc   +1 more source

Geometry‐Related Technical Complications After LVAD Implantation: Impact on Device Dysfunction and Clinical Outcomes

Artificial Organs, EarlyView.
Preventable geometric failure modes, such as outflow graft kinking and inflow malposition, frequently cause HeartMate 3 dysfunction. This study identifies these complications as key drivers of device‐related morbidity, highlighting the importance of optimized surgical positioning to ensure long‐term device performance and improved clinical outcomes ...
Ali Saad Merzah, Ezin Deniz, Sara Knigge, Jasmin Hanke, Alina Zubarevich, Mohamad Dia, Chaikovska Sofia, Todurov Borys, Saeed Torabi, Bastian Schmack, Alexander Weymann, Zurab Darbaidze, Josephina Haunschild, Christian D. Etz, Max Biewer, Arjang Ruhparwar, Jan D. Schmitto, Günes Dogan   +17 more
wiley   +1 more source

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

Artificial Organs, EarlyView.
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov, Sara Yousefzada, Isabell A. Just, Christoph Klein, Evgenij Potapov, Santiago Garcia, Dhairya Patel, Lauren S. Ranard, Arseniy Goncharov, Dean J. Kereiakes, Raj R. Makkar, Torsten P. Vahl, Tanja K. Rudolph, Axel Unbehaun   +13 more
wiley   +1 more source

Long-term evaluation of TTK Chitra™ heart valve prosthesis - a retrospective-prospective cohort study. [PDF]

Indian J Thorac Cardiovasc Surg, 2023
Varma PK, Vijayakumar M, Bhuvaneshwar GS, Kumar AS, Krishna N.   +4 more
europepmc   +1 more source

A guide to the ecological limitations of phage therapy of bacterial biofilms: Is what's best for the phage best for the physician?

The FEBS Journal, EarlyView.
Bacteriophages—viruses that kill bacteria—are promising weapons against bacterial biofilms: sessile communities notoriously resistant to antibiotics. Yet phages evolved not so much to eradicate bacteria as to obtain new bacteria to infect. That goal, however, may conflict with the physician's objective of complete bacterial clearance.
Stephen T. Abedon
wiley   +1 more source